James W. Cox, M.S.
Senior Scientist
 

 
T: 202-266-5037
F: 202-557-3836
 
Download vCard
 
EDUCATION:

BS, Towson University, Cell and Molecular Biology, 2010

MS, Towson University, Biology, 2013

 
 

PRINT

James W. Cox, MS, Senior Scientist with The Acta Group (Acta®), is an experienced biologist and risk assessor who has reviewed hundreds of industrial chemicals, biological agents, nanomaterials, and novel chemistries to assess environmental and human health risks. Mr. Cox offers clients technical excellence and seasoned regulatory process guidance for products subject to the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and other federal and state chemical regulatory programs. Mr. Cox provides expertise in the collection and analysis of data; the design, evaluation, and development of models; and the presentation of scientific data in a clear and defensible manner to support chemical submissions.

Prior to joining Acta, Mr. Cox most recently served as Acting Lead Biologist in Risk Assessment Branch 1, New Chemicals Division, Office of Pollution Prevention and Toxics (OPPT) of the U.S. Environmental Protection Agency (EPA), having held positions of increasing responsibility and scope since joining OPPT. He served as Chair of the Risk Assessment Division’s (RAD) Hazard and Risk Assessment Technical Team and was a key member of the team providing analysis and recommendations to inform EPA Office of Chemical Safety and Pollution Prevention’s (OCSPP) policy on new approach methodologies (NAM).

Prior to his career at EPA OPPT, Mr. Cox was a biologist with the U.S. Department of Defense (DoD), serving in the toxicology directorate of the U.S. Army Public Health Center at Aberdeen Proving Ground, Maryland, and a public safety officer with the State of Maryland.

Publications:

W.C. Stanley, J.W. Cox, G. Asemu, K. O’Connell, E. Dabkowski, W. Xu, R.F. Ribeiro Jr., K.C. Shekar, S.W. Hoag, S. Rastogi, N. Hani, C. Daneault, and C. des Rosiers “Evaluation of Docosahexaenoic Acid in a Dog Model of Hypertension Induced Left Ventricular Hypertrophy.” Journal of Cardiovascular Translational Research (2013), Vol. 6(6), 1000-1010.

G. Asemu, K.A. O’Connell, J.W. Cox, E.R. Dabkowski, W. Xu, R.F. Ribeiro Jr., K.C. Shekar, P.A. Hecker, S. Rastogi, H.N. Sabbah, C.L. Hoppel, and W.C. Stanley “Enhanced Resistance to Permeability Transition in Interfibrillar Cardiac  Mitochondria in Dogs: Effects of Aging and Long-Term Aldosterone Infusion.” American Journal of Physiology – Heart and Circulatory Physiology (2012), Vol. 304(4), H514-H528.

P.A. Hecker, V. Lionetti, R.F. Ribeiro Jr., S. Rastogi, B.H. Brown, K.A. O’Connell, J.W. Cox, K.C. Shekar, D.M. Gamble, H.N. Sabbah, J.A. Leopold, S.A. Gupte, F.A. Recchia, and W.C. Stanley “Glucose 6- Phosphate Dehydrogenase Deficiency Increases Redox Stress and Moderately Accelerates the Development of Heart Failure.” Circulation. Heart Failure (2012), Vol. 6(1), 118-126.

P.A. Hecker, R.F. Mapanga, C.P. Kimar, R.F. Ribeiro Jr., B.H. Brown, K.A. O’Connell, J.W. Cox, K.C. Shekar, G. Asemu, M.F. Essop, and W.C. Stanley “Effects of Glucose 6-Phosphate Dehydrogenase Deficiency on the Metabolic and Cardiac Responses to Obesogenic or High Fructose Diets.” American Journal of Physiology - Endocrinology and Metabolism (2012) 303, E959-E972.


 
THE ACTA GROUP
Beijing, China | Brussels, Belgium | Manchester, U.K. | Washington, D.C.
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy
©2022 The Acta Group All Rights Reserved.